The European Society for Medical Oncology (ESMO) presented a new drug, ET743, which has shown promising results in treating advanced ovarian cancer. In a clinical trial, the drug reduced tumors in 47% of patients, with some experiencing complete responses.
A new study found that chemotherapy and radiotherapy together reduce surgery and removal of the voice box due to cancer recurrence. The combination treatment was associated with a significantly lower rate of surgeries compared to standard therapy or radiotherapy alone.
Researchers have found an increased risk of nonmelanoma skin cancer among childhood cancer survivors, with the University of Minnesota presenting their findings at the American Society of Clinical Oncology meeting. The study's lead author notes that further research is needed to determine why this association exists.
Research reveals that survivors of childhood cancer are experiencing significant sleep disturbances even years after completing treatment. The University of Minnesota study aims to investigate the causes and effects of these issues.
A new study suggests that CT readings at oncology centers differ from those at general hospitals, affecting relative value unit assessments (RVUs). The average length of CT reports and character counts were significantly higher at oncology centers, with prior scans being directly compared more often.
A new phthalocyanine compound, Pc 4, targets cancerous cells preferentially, leaving healthy tissue alone. The treatment uses laser light to activate the drug, producing forms of oxygen that kill cancer cells and break down tumors.
Screening for colorectal cancer is vital for early detection, with a significant reduction in mortality rates associated with early detection. Current techniques like colonoscopy are effective but expensive, prompting the need for alternative methods.
A new information structure called Point of Information and Support (PIS) has been shown to reduce patients' anxiety and depression by providing personalized health information. The PIS comprises a library with booklets, videos, and essential information about cancer types and drugs.
Research by Dr Anne Chantal Braud and her team has shown that older women with breast cancer can tolerate powerful medication, contradicting initial expectations. The study examined the effects of surgery, radiotherapy, chemotherapy, and hormone therapy on 179 women over 70 years old.
Key findings from the ESMO Congress emphasize the need for better care and communication in cancer treatment. Patients must be informed and involved in their treatment decisions, while healthcare professionals should prioritize empathy and understanding. A European cancer patient coalition is proposed to amplify patients' voices.
A new chip technology is being developed to analyze cancer genes, promising faster and more accurate diagnoses. The technology uses DNA microarrays to screen thousands of genes simultaneously, allowing for quicker testing than current methods.
Women with stage IIIb cervical cancer may benefit from different treatments depending on the spread of their disease, according to a new study. The research found that women whose cancer had not spread to lymph nodes had the highest survival rates, while those with upper chest lymph node involvement typically died within months.
Researchers found that combining whole brain radiation with stereotactic radiosurgery improved survival rates by one to two months for patients with single brain metastases. Those with multiple metastases showed some improvement in survival, but not as much, and added medications may further enhance treatment outcomes.
Leading oncology experts emphasize the need for additional research among elderly cancer patients with co-morbid conditions and those taking multiple medications. They advocate for equal access to treatment options as younger patients, highlighting a lack of focus on this critical patient population.
Researchers conducted a Phase I clinical trial of endostatin, showing that it decreases blood flow to tumors and promotes the death of cancer cells. The study also found minor anti-tumor activity in two patients, but no long-term responses were seen.
A new study published in the Journal of Clinical Oncology found that a healthy diet does not significantly affect Prostate-Specific Antigen (PSA) levels over a relatively short period. The researchers believe that longer-term dietary effects on prostate cancer are still unknown.
Researchers at Emory University's Winship Cancer Institute are studying cellular responses to environmental stress to better understand how it contributes to cancer development. The team aims to characterize networks of systems that operate during exposure to DNA-damaging events, with a focus on DNA repair and damage tolerance pathways.
A study published in Journal of Clinical Oncology found that self-taught stress management techniques, such as progressive muscle relaxation and guided imagery, can significantly improve the quality of life for cancer patients undergoing chemotherapy. These techniques were more effective than traditional methods when learned independen...
Chernobyl exposure linked to increased thyroid cancer in children, while HRT use may increase breast-cancer risk with long-term use. The Lancet Oncology reviews these findings and highlights the need for prospective trials. Increasing age is associated with rising cancer incidence, making geriatric oncology crucial.
A study by UCSF found that cancer patients often prefer to experience pain over the side effects of opioid analgesics. Effective pain management requires repeated assessment and adjustments in dosage, according to experts.
A study published in the Journal of Clinical Oncology found PET scans to be more accurate than CT scans in detecting cervical cancer spread. The imaging method reveals metabolic differences between cancer cells and normal tissue, identifying abnormal lymph nodes.
A new study published in Psycho-Oncology found that people with advanced cancer are more willing to consider toxic chemotherapy regimens, even if they offer only minimal benefits. Cancer patients generally accepted both milder and riskier treatments, unlike healthy individuals and healthcare professionals.
A study published in Psycho-Oncology found that support groups significantly reduced anxiety among children aged 7-18 whose sibling was treated for leukemia, lymphoma, or other cancers. The five-session program enhanced feelings of control, allowing children to share experiences and emotions, and teaching them coping strategies.
A study published in Journal of Clinical Oncology finds that family caregiving for elderly patients with cancer translates to an average yearly cost of $1,200 per patient and about $1 billion nationally. Informal care is often overlooked when estimating total costs of cancer treatment.
Researchers at Johns Hopkins Oncology Center discovered a genetic alteration in tumor samples that predicts patient response to chemotherapy. The methyl-guanine-DNA methyltransferase (MGMT) gene was found to be altered in 19 patients, resulting in better responses to chemotherapy and increased long-term survival.
The Puget Sound Oncology Consortium is partnering with the National Surgical Adjuvant Breast and Bowel Project to evaluate Herceptin therapy in women with early stage breast cancer. The trial, Protocol B-31, aims to assess the safety and efficacy of combining Herceptin with chemotherapy in treating node-positive breast cancer patients.
A new diagnostic tool is highly accurate in detecting cancer spread in women with vulva cancer, potentially sparing them from debilitating lymph node removal. Researchers found that 27 out of 59 patients had cancer spread, and the procedure could spare up to 80% of women from this procedure.
Researchers found that patients with localized prostate cancer who received higher doses of radiation lived longer and had better local control of their cancer. The study, published in the Journal of Clinical Oncology, examined data from 1560 patients treated between 1975 and 1995.
Dr. Yoav Horn founded the West Bank Cancer Program in 1978, helping to establish two oncology treatment centers and train Palestinian physicians. The program improved early cancer treatment and saved lives, according to data from a computerized registry of over 7,000 patient records.
Researchers at Johns Hopkins presented Phase I study results for Taxoprexin DHA-paclitaxel, a novel taxane that tolerates high doses with minimal side effects. The drug delivers more therapeutic agent to tumor cells and less to healthy tissues, improving safety and effectiveness.
Researchers found that concurrent chemotherapy and daily chest radiation can help lung cancer patients live longer, with an average survival of 17 months. In contrast, sequential treatment resulted in an average survival of 14.6 months.
Researchers at Johns Hopkins Medicine have developed a technology called Conversion that dramatically improves the accuracy of genetic tests for cancer risk. The technology separates alleles, allowing for individual analysis and detection of previously missed genetic alterations.
A new pediatric cancer program in El Salvador has shown remarkable success, achieving remission and cure rates of over 80% for children with acute lymphoblastic leukemia. This model program, developed by St. Jude Children's Research Hospital, aims to improve survival rates for children with cancer worldwide.
Researchers at Thomas Jefferson University have found that radiation therapy helps patients with localized prostate cancer live longer. After examining the results of 1560 patients who received radiation therapy alone for prostate cancer, they discovered that those with high-risk disease benefited the most from higher doses of radiation.
High-dose cyclophosphamide treatment achieved complete remissions in five patients with autoimmune disorders, while partial remissions were maintained in two. Patients experienced improved kidney function and reduced medication doses.
Researchers at UT Southwestern Medical Center have shown that the transmission of mtDNA in yeast is organized and finite, rather than random. This discovery has implications for understanding genetic disorders caused by mtDNA mutations in humans, where the mother passes on a minority of her mtDNA copies to the fetus.
Researchers at Johns Hopkins Oncology Center identify connection between APC and c-MYC genes, which conspire to initiate almost all colon cancers. The study suggests potential new drug strategies to prevent colon cancer by blocking the signal that activates c-MYC.
A new computer program called POMPOUS has been developed to predict genetic markers with high accuracy, accelerating the discovery of gene function and reducing costs. The program has identified over 13,000 markers on the human genome, enabling researchers to analyze and identify genes more efficiently.
A recent study published in the American Society for Therapeutic Radiology and Oncology found that children with soft tissue sarcomas who did not respond well to chemotherapy can benefit from radiation therapy. The treatment was shown to improve survival rates by up to 40% in this patient population.
Scientists have identified a key genetic pathway responsible for 90 percent of colon cancers, which could lead to the development of targeted therapies. The mutation of the APC gene disrupts normal cell regulation, causing uncontrolled growth and cancer.